CB
GSK icon

Chemical Bank’s GSK GSK Stock Holding History

Chemical Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,855
Closed -$201K – 348
2019
Q1 		$201K Buy
+3,855
New +$193K 0.02% 340
2018
Q4 		– Sell
-4,015
Closed -$202K – 350
2018
Q3 		$202K Sell
4,015
-145
-3% -$7.37K 0.02% 357
2018
Q2 		$210K Sell
4,160
-104
-2% -$5.24K 0.02% 348
2018
Q1 		$208K Sell
4,264
-840
-16% -$39.1K 0.02% 356
2017
Q4 		$226K Sell
5,104
-480
-9% -$22.2K 0.02% 345
2017
Q3 		$283K Sell
5,584
-8,310
-60% -$422K 0.03% 319
2017
Q2 		$749K Sell
13,894
-181
-1% -$9.65K 0.08% 200
2017
Q1 		$742K Buy
14,075
+204
+1% +$10.3K 0.08% 196
2016
Q4 		$668K Buy
13,871
+1,091
+9% +$53.9K 0.08% 200
2016
Q3 		$689K Sell
12,780
-120
-0.9% -$6.58K 0.09% 175
2016
Q2 		$699K Sell
12,900
-289
-2% -$15.2K 0.1% 176
2016
Q1 		$668K Buy
13,189
+80
+0.6% +$3.98K 0.09% 180
2015
Q4 		$661K Sell
13,109
-855
-6% -$43.6K 0.09% 179
2015
Q3 		$672K Sell
13,964
-1,740
-11% -$90.6K 0.1% 184
2015
Q2 		$817K Sell
15,704
-320
-2% -$18K 0.11% 179
2015
Q1 		$925K Buy
16,024
+40
+0.3% +$2.29K 0.12% 167
2014
Q4 		$854K Buy
15,984
+720
+5% +$40.3K 0.11% 180
2014
Q3 		$877K Buy
15,264
+5,660
+59% +$347K 0.15% 142
2014
Q2 		$642K Buy
9,604
+1,200
+14% +$81.2K 0.11% 170
2014
Q1 		$561K Sell
8,404
-1,242
-13% -$84K 0.1% 175
2013
Q4 		$644K Hold
9,646
– – 0.11% 164
2013
Q3 		$605K Sell
9,646
-280
-3% -$18K 0.12% 166
2013
Q2 		$620K Buy
+9,926
New +$630K 0.12% 160

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Chemical Bank's GSK Position: Q2 2019 in Review

Chemical Bank sold out of GSK (GSK) in Q2 2019, closing a stake of 3,855 shares — an estimated $201K sold.

Chemical Bank first reported a position in GSK in Q2 2013 and held it in 23 quarters. The position peaked at $925K in Q1 2015. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • Chemical Bank reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
  • Chemical Bank sold 3,855 GSK shares in Q2 2019, an estimated $201K.
  • Chemical Bank first reported a position in GSK in Q2 2013 and held it in 23 quarters.
  • Chemical Bank's GSK position peaked at $925K in Q1 2015.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.